Cadila Healthcare Limited Losartan Export Data — India (DGFT 2022–2026)

Name: Cadila Healthcare Limited Losartan Export Records India — #13 Exporter, 72 Shipments, $3.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Losartan

India Pharmaceutical Trade Intelligence

$301.0M506 Suppliers141 CountriesHS 30049073

ExportsIndia → UNITED STATES44.6%India → PHILIPPINES10.6%

ImportsISRAEL → India$24.8M SPAIN → India$4.5M

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Cadila Healthcare Limited — Losartan Exporter #13 | $3.6M Trade Value | TransData Nexus | TransData Nexus

Cadila Healthcare Limited — Losartan Exporter Profile

Indian Pharmaceutical Exporter · #13 for Losartan · $3.6M export value · DGFT Verified

Cadila Healthcare Limited is the #13 Indian exporter of Losartan with $3.6M in export value and 72 verified shipments. Cadila Healthcare Limited holds a 1.2% market share in Losartan exports across 11 countries. The company exports 41 pharmaceutical products worth $34.9M across 17 therapeutic categories.

Cadila Healthcare Limited — Losartan Export Profile: Buyers & Destinations

Cadila Healthcare Limited Losartan export treemap — buyers and destination countries | TransData Nexus

Where Does Cadila Healthcare Limited Export Losartan?

Country	Value	Shipments	Share
UNITED STATES	$2.0M	44	57.4%
SRI LANKA	$690.9K	21	19.7%
THAILAND	$444.1K	13	12.7%
VIETNAM	$150.0K	3	4.3%
UGANDA

Who Are the Top Buyers of Losartan from Cadila Healthcare Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$1.9M	41
SUNSHINE HEALTHCARE LANKA LIMITED	SRI LANKA	$640.9K	20
PHARMALAND 1982 CO LIMITED	THAILAND	$347.4K	10
PRIORITY HEALTHCARE DISTRIBUTION DB	UNITED STATES	$150.0K	3
BEN TRE PHARMACEUTICAL JOINT STOCK	VIETNAM	$100.0K	2
PHARMALAND 1982 CO LTD	THAILAND	$96.7K	3
ABACUS PHARMA AFRICA LTD	KENYA	$51.1K	2
BEN TRE PHARMACEUTICAL JOINT-STOCK	VIETNAM	$50.0K	1
ABACUS PHARMA AFRICA LIMITED	UGANDA	$50.0K	1
SUNSHINE HEALTHCARE LANKA LTD	SRI LANKA	$50.0K	1

Cadila Healthcare Limited supplies Losartan to 19 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA) and PHARMALAND 1982 CO LIMITED (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Losartan Formulations Does Cadila Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
LOSACAR 50 MG TAB 15X7 TABLOSARTAN POTA	$209.2K	5
LOSACAR 50 MG TAB 15X7 TABLOSARTAN POTASSIUM15X7	$200.0K	4
LOSARTAN POTASSIUM 100 MG 1X90T DIST. NDC - 68382-137-16 MANUFACTURING . NDC - 65841-731-16AS PER INVOICE. & P.LIST	$190.3K	4
LOSARTAN POTASSIUM 50 MG 1X90T DIST. NDC- 68382-136-16 MANUFACTURING . NDC - 65841-730-16AS PER INVOICE. & P.LIST	$188.5K	4
LOSARTAN POTASSIUM 50 MG 1X90T	$150.0K	3
LOSARTAN POTASSIUM 100 MG 1X90T	$141.1K	3
PHARMA : LOSARTAN POTASSIUM 50 MG LOSAR	$135.5K	3
LOSARTAN POTASSIUM 100 MG 1X90T DIST. ND	$127.6K	3
PHARMA : LOSARTAN POTASSIUM 100 MG LOSA	$111.3K	3
LOSACAR 50MG TAB LOSARTANE POTASSIUM 50	$98.7K	2

Cadila Healthcare Limited exports 63 distinct Losartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOSACAR 50 MG TAB 15X7 TABLOSARTAN POTA with 5 shipments worth $209.2K.

How Does Cadila Healthcare Limited Compare to Nearest Losartan Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
14	AUROBINDO PHARMA LIMITED	$5.1M	159	5	$32.2K
15	UNICHEM LABORATORIES LIMITED	$5.1M	203	6	$25.0K
13	CADILA HEALTHCARE LIMITED ★	$3.6M	72	11	$50.0K
7	AJANTA PHARMA LIMITED	$3.5M	69	2	$50.0K
10	APL HEALTHCARE LIMITED	$1.9M	38	1	$50.0K

Cadila Healthcare Limited ranks #13 among 506 Indian Losartan exporters. Average shipment value of $50.0K compared to the market average of $283.3K. The closest competitors by value are AUROBINDO PHARMA LIMITED and UNICHEM LABORATORIES LIMITED.

Which Indian Ports Ship Losartan Exports?

Port	Shipments	% Share
SAHAR AIR	1,020	9.4%
NHAVA SHEVA SEA (INNSA1)	946	8.7%
SAHAR AIR CARGO ACC (INBOM4)	886	8.1%
DELHI AIR CARGO ACC (INDEL4)	702	6.4%
DELHI AIR	672	6.2%
JNPT/ NHAVA SHEVA SEA	549	5.0%
MUNDRA SEA	491	4.5%
HYDERABAD ICD	384	3.5%

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Losartan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zydus. The escalating conflict in the Middle East has disrupted key maritime routes, particularly the Red Sea and Suez Canal, leading to longer transit times and increased freight costs. Major carriers have suspended or restricted transits, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes. (livemint.com) This situation poses significant challenges for time-sensitive pharmaceutical shipments, especially temperature-sensitive medicines. (economictimes.indiatimes.com)

Conversely, U.S.–China trade tensions have prompted the U.S. to impose tariffs on Chinese pharmaceutical imports, creating an opportunity for Indian exporters to fill the supply gap. However, the U.S. has also introduced tariffs on Indian imports, including a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) While pharmaceuticals are currently exempt, the potential for future tariffs necessitates strategic planning.

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial. The FMD mandates stringent serialization and traceability requirements to prevent counterfeit medicines from entering the supply chain. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU Good Manufacturing Practice (GMP) guidelines set stringent quality benchmarks. Any lapses can lead to import alerts, product recalls, or facility shutdowns. For instance, in 2019, Zydus's Moraiya facility received an Official Action Indicated (OAI) classification from the U.S. FDA, indicating that regulatory and/or administrative actions were recommended. (moneycontrol.com) Such events underscore the importance of robust quality assurance systems.

The evolving regulatory landscape demands continuous investment in compliance infrastructure. The EU's Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act (DSCSA) require advanced serialization and traceability measures. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Losartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cadila Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 97 individual customs records matching Cadila Healthcare Limited exporting Losartan, covering 63 formulations to 13 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 141+ countries, 1,415+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Losartan

Losartan

Cadila Healthcare Limited — Losartan Exporter Profile

Cadila Healthcare Limited — Losartan Export Profile: Buyers & Destinations

Where Does Cadila Healthcare Limited Export Losartan?

Who Are the Top Buyers of Losartan from Cadila Healthcare Limited?

What Is India's Total Losartan Export Value and How Much Does Cadila Healthcare Limited Contribute?

What Is the Average Shipment Value for Cadila Healthcare Limited's Losartan Exports?

How Does Cadila Healthcare Limited Compare to Other Indian Losartan Exporters?

What Losartan Formulations Does Cadila Healthcare Limited Export?

Regulatory Requirements: Exporting Losartan to Key Markets

United States — FDA

How Does Cadila Healthcare Limited Compare to Nearest Losartan Exporters?

Which Indian Ports Ship Losartan Exports?

What Other Cardiovascular Products Does Cadila Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Losartan Exports

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

About Cadila Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Losartan Export Data from Cadila Healthcare Limited

Losartan Stats

Company Overview

Top Products by Cadila Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source